コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 hy was prevented by transgenic expression of superoxide dismutase 1.
2 axin-3 as well as mutant alpha-synuclein and superoxide dismutase 1.
3 vels of superoxide in a yeast mutant lacking superoxide dismutase 1.
4 which accumulate intracellular aggregates of superoxide dismutase-1.
6 events palmitoylation, leads to reduction in superoxide dismutase-1 activity in vivo and in vitro, an
8 ng the novel palmitoylproteins identified is superoxide dismutase-1, an intensively studied enzyme th
11 th downregulation of the antioxidant enzymes superoxide dismutase 1 and catalase, and activation of t
12 anscription and translation of antioxidants, superoxide dismutase 1 and glutathione peroxidase-1, wer
13 o oxidized glutathione, and up-regulation of superoxide dismutase 1 and heat shock protein 70, all co
16 tholog of human DJ-1/Park7, gamma-synuclein, superoxide dismutase 1), anti-oxidant proteins (peroxire
18 ies showed that astrocytes expressing mutant superoxide dismutase 1 are toxic to normal motoneurons.
20 ain increased vulnerability, including SOD1 (superoxide dismutase 1), catalase, glutathione S-transfe
22 terfering RNA targeting copper chaperone for superoxide dismutase 1 (CCS) suppressed hypoxia-induced
23 coimmunoprecipitates with a Cu chaperone for superoxide dismutase-1 (CCS), and gene silencing of CCS,
25 ds previously were reported to inhibit Cu/Zn superoxide dismutase 1 dependent protein aggregation and
28 t a key region identified at the core of the superoxide dismutase-1 fibrillar aggregates, beta-barrel
29 from the expression of mutant proteins (G85R superoxide dismutase 1; G59S p150(glued)) that cause fam
31 express the G93A mutation of the human Cu-Zn superoxide dismutase 1 gene (hSOD1(G93A) mice) are a com
33 er-expressing the G93A mutation of the Cu/Zn superoxide dismutase 1 gene) of ALS enters a progressive
35 made of tau, alpha-synuclein, huntingtin and superoxide dismutase 1 has been demonstrated, revealing
36 ve post-translational modifications of human superoxide dismutase 1 (hSOD1) in the amyotrophic latera
37 uced accumulation of chloroplast copper/zinc superoxide dismutase 1 (HvSOD1), whereas loss of functio
38 uced accumulation of chloroplast copper/zinc superoxide dismutase 1 (HvSOD1), whereas loss of functio
39 ly, when overproduced, Atx1p substitutes for superoxide dismutase 1 in preventing oxidative damage; h
40 ns (polyglutamine, huntingtin, ataxin-1, and superoxide dismutase-1) inhibits clathrin-mediated endoc
42 bdb) model of diabetic polyneuropathy and 2) superoxide dismutase 1 knockout (Sod1(-/-) ) mouse model
43 d significantly higher glutathione and Cu-Zn superoxide dismutase 1 levels compared with ALS/Lt islet
44 ssion of the G985R and G93A mutated forms of superoxide dismutase 1 (linked to familial amyotrophic l
45 specifically discussed: transthyretin, p53, superoxide dismutase 1, lysozyme, serum amyloid A, prion
46 the transcriptional profile of human mutant superoxide dismutase 1 motor neurons has remained undisc
47 se, delays disease progression in the mutant superoxide dismutase 1 mouse model of amyotrophic latera
49 tion and disease propagation in mutant human superoxide dismutase 1 (mSOD1)-mediated amyotrophic late
53 motor neuron degeneration produced by mutant superoxide dismutase-1 (mSOD1), the only proven cause of
55 identified F- and S-type motoneurons in the superoxide dismutase-1 mutant G93A (mSOD1), a mouse mode
57 sing an amyotrophic lateral sclerosis-linked superoxide dismutase-1 mutation led to the idea that pro
60 rimary astrocytes isolated from mutant human superoxide dismutase 1-overexpressing mice as well as hu
62 -1 (CCS), and gene silencing of CCS, but not superoxide dismutase-1, prevents IGF-1- or Cu-induced HI
63 3/STAT3) protein, and (5) coronary arteriole superoxide dismutase 1 protein; or had increases in (6)
65 rone activity toward its physiologic target, superoxide dismutase 1, rather than proteasomal degradat
66 g to laser captured motor neurons from human superoxide dismutase 1-related amyotrophic lateral scler
67 ellular and animal model work has focused on superoxide dismutase 1-related amyotrophic lateral scler
68 ssed genes in spinal cord motor neurons from superoxide dismutase 1-related amyotrophic lateral scler
69 e in the propagation of motoneuron injury in superoxide dismutase 1-related amyotrophic lateral scler
70 ion of in vivo and in vitro model systems of superoxide dismutase 1-related amyotrophic lateral scler
71 termine those pathways dysregulated in human superoxide dismutase 1-related neurodegeneration and to
72 ymptomatic transgenic mice expressing mutant superoxide dismutase 1 revealed two striking changes.
74 were down-regulated: copper-zinc-containing superoxide dismutase 1 (SOD-1), insulin-like growth fact
75 neration: In mice that overexpress wild-type superoxide dismutase-1 (SOD(WT)), axons show chronic tra
77 ral sclerosis (FALS)-associated mutant Cu/Zn superoxide dismutase-1 (SOD) induces apoptosis of neuron
79 om an in silico screen that stabilize mutant superoxide dismutase-1 (SOD-1) linked to familial amyotr
80 e effects of overexpression of Cu(2+)/Zn(2+) superoxide dismutase-1 (SOD-1) on indexes of renal injur
82 duced expression of the antioxidant enzymes: superoxide-dismutase 1 (SOD-1), SOD-2, and catalase thro
83 e enhanced by expression of a mutant form of superoxide dismutase 1 (SOD1 G93A) that causes astrocyte
87 murine model in which a pathogenic mutant of superoxide dismutase 1 (SOD1(G93A)) is expressed in an A
89 Using a mouse model of ALS expressing mutant superoxide dismutase 1 (SOD1(G93A)), we show that motor
90 Overexpression of a familial mutant form of superoxide dismutase 1 (SOD1) (G93A) in neuroblastoma ce
92 ive diseases such as ALS, where mutations of superoxide dismutase 1 (SOD1) account for about 20% of t
94 storing the activity of antioxidant enzymes, superoxide dismutase 1 (SOD1) and peroxiredoxin-4 (PRDX4
100 and gene expression analysis, we now propose superoxide dismutase 1 (SOD1) as the most likely target
104 One of the mechanisms by which mutations in superoxide dismutase 1 (SOD1) cause familial amyotrophic
105 ch DNA-damaging agents, NGF deprivation, and superoxide dismutase 1 (SOD1) depletion evoke apoptosis
106 uired for copper-dependent activation of the superoxide dismutase 1 (SOD1) during spore germination.
107 rom mice carrying ALS-linked mutant forms of superoxide dismutase 1 (SOD1) exhibit an increased sensi
108 domain that requires the host cell cofactor superoxide dismutase 1 (SOD1) for activation, while the
109 pase-11 is upregulated in the spinal cord of superoxide dismutase 1 (SOD1) G93A transgenic mice, a mo
111 clear genetic link to point mutations in the superoxide dismutase 1 (SOD1) gene has been shown in a s
112 ALS based upon dominant mutations within the superoxide dismutase 1 (SOD1) gene, which account for <2
114 Transgenic overexpression of Cu(+2)/Zn(+2) superoxide dismutase 1 (SOD1) harboring an amyotrophic l
115 ced aggregation of the dimeric enzyme Cu, Zn superoxide dismutase 1 (SOD1) has been implicated in the
117 Transgenic mouse models expressing mutant superoxide dismutase 1 (SOD1) have been critical in furt
120 shown that ALS-associated mutations in Cu/Zn superoxide dismutase 1 (SOD1) impair axonal transport of
121 e in mice harboring mutations of copper-zinc superoxide dismutase 1 (SOD1) in familial amyotrophic la
122 rew-like structure of a cytotoxic segment of superoxide dismutase 1 (SOD1) in its oligomeric state.
123 al behavior of the pathogenic A4V variant of superoxide dismutase 1 (SOD1) in the metal-free (apo) fo
124 ation kinetics of the ALS-associated protein superoxide dismutase 1 (SOD1) in vitro and in transgenic
126 ghput screening assay targeting mutant Cu/Zn superoxide dismutase 1 (SOD1) induced toxicity and aggre
127 cological inhibition or genetic knockdown of superoxide dismutase 1 (SOD1) inhibits the functional ho
130 e find that injection of oligomers of mutant superoxide dismutase 1 (SOD1) into the cytoplasm of inve
133 -of-function" toxic property of mutant Cu-Zn superoxide dismutase 1 (SOD1) is involved in the pathoge
135 oxidative damage through genetic ablation of superoxide dismutase 1 (SOD1) leads to abnormalities in
138 xamined in ALS2-deficient mice and in mutant superoxide dismutase 1 (SOD1) mice that develop ALS-like
139 asked if decreasing metabolism in the mutant superoxide dismutase 1 (SOD1) mouse model of ALS (G93A S
141 ally bind and neutralize misfolded and toxic superoxide dismutase 1 (SOD1) mutant proteins may find a
142 Two of the models (polyalanine (37A) and superoxide dismutase 1 (SOD1) mutants A4V and G85R) accu
143 re that amyotrophic lateral sclerosis-linked superoxide dismutase 1 (SOD1) mutants with different bio
144 associated with the most common copper/zinc superoxide dismutase 1 (SOD1) mutation, an alanine for v
146 owever, the mechanistic relationship between superoxide dismutase 1 (SOD1) mutations and human diseas
148 cells, were either decreased by a mimetic of superoxide dismutase 1 (SOD1) or by overexpressing SOD1
150 ophic lateral sclerosis-associated cytosolic superoxide dismutase 1 (SOD1) protein between motor neur
152 lateral sclerosis (ALS)-causing mutations in superoxide dismutase 1 (SOD1) provokes noncell autonomou
153 on in a well-validated cell-culture model of superoxide dismutase 1 (SOD1) related familial MND (fMND
154 Determining the composition of aggregated superoxide dismutase 1 (SOD1) species associated with am
156 one or more toxic function(s) on copper/zinc superoxide dismutase 1 (SOD1) that impair motor neuron v
157 ic lateral sclerosis (ALS) have mutations in superoxide dismutase 1 (SOD1) that increase the denitros
158 Notably, G85R is a mutant version of Cu/Zn superoxide dismutase 1 (SOD1) that is unable to reach na
160 r assembly of cytochrome c oxidase (CcO) and superoxide dismutase 1 (Sod1) within the intermembrane s
161 immunity were investigated in the CNS of the Superoxide Dismutase 1 (SOD1)(G93A) transgenic mouse mod
164 Interestingly, the addition of bovine liver superoxide dismutase 1 (SOD1), a known activator of P. a
165 x-deficient mice with mice expressing mutant superoxide dismutase 1 (SOD1), a transgenic model of fam
166 signal sequence lacking cytoplasmic protein, superoxide dismutase 1 (SOD1), and its mutant form linke
167 ALS patients known not to carry mutations in superoxide dismutase 1 (SOD1), as well as from 75 sporad
169 ies by overexpressing the antioxidant enzyme superoxide dismutase 1 (SOD1), in a transgenic mouse, in
170 human and yeast copper chaperones (CCS) for superoxide dismutase 1 (SOD1), long thought to exclusive
171 ction and determined the in vivo kinetics of superoxide dismutase 1 (SOD1), mutation of which causes
172 we found that antisense oligonucleotides to superoxide dismutase 1 (SOD1), one of the most abundant
176 In mice expressing ALS-associated mutant superoxide dismutase 1 (SOD1), VEGF mRNA expression in t
177 uppressed by oligomers of mutant human Cu/Zn superoxide dismutase 1 (SOD1), which are associated with
179 was enriched in astrocytes expressing mutant superoxide dismutase 1 (SOD1), which causes familial amy
180 he dynamic motions within the beta-barrel of superoxide dismutase 1 (SOD1), which previously were imp
181 viously been found to be inhibitors of Cu/Zn superoxide dismutase 1 (SOD1)-dependent protein aggregat
182 ngly slows disease in mouse models of mutant superoxide dismutase 1 (SOD1)-induced amyotrophic latera
184 croglial phenotypes in preclinical stages of superoxide dismutase 1 (SOD1)-mutant-mediated disease.
193 S100; transcription factor ERG; antioxidant superoxide dismutase 1 (SOD1); chloride intracellular ch
196 gene coding for the mutated G93A form of the superoxide dismutase-1 (SOD1(G93A)), even when treatment
197 sregulation has been shown to correlate with superoxide dismutase-1 (SOD1) aggregation in a cellular
198 f ALS cases are sporadic, mutations in Cu-Zn superoxide dismutase-1 (SOD1) are causative for 10-20% o
203 This article investigates how the rate of superoxide dismutase-1 (SOD1) fibrillization is affected
204 (ALS) cases were linked to mutations in the superoxide dismutase-1 (SOD1) gene, a substantial propor
205 ) cases are associated with mutations of the superoxide dismutase-1 (SOD1) gene, and the 'D90A' mutat
208 increasing evidence that toxicity of mutant superoxide dismutase-1 (SOD1) in amyotrophic lateral scl
213 d in transgenic mice expressing both APP and superoxide dismutase-1 (SOD1) or in APP transgenics in w
214 Abnormal assemblies formed by misfolded superoxide dismutase-1 (SOD1) proteins are the likely ca
215 , we have used mice expressing a mutation in superoxide dismutase-1 (SOD1) that is linked to amyotrop
216 trochemical setup and use the specificity of superoxide dismutase-1 (SOD1) to show, for the first tim
218 ly gene (IEG) proteins and the HSA21 protein superoxide dismutase-1 (SOD1) were found in the hippocam
220 ALS) is linked to over 90 point mutations in superoxide dismutase-1 (SOD1), a dimeric metalloenzyme.
221 als essential for the activity of the enzyme superoxide dismutase-1 (SOD1), a potential target for an
222 ))ATSM enhanced the association of DJ-1 with superoxide dismutase-1 (SOD1), paralleled by significant
223 use models of familial ALS expressing mutant superoxide dismutase-1 (SOD1), TAR DNA-binding protein 4
225 electrophoresis to measure the net charge of superoxide dismutase-1 (SOD1)--whose aggregation causes
230 ch using a standard animal model, the mutant superoxide dismutase-1 (SOD1)mouse, has revealed deficit
231 nherited ALS caused by dominant mutations in superoxide-dismutase 1 (SOD1) were identified by using g
232 c slice cultures from a mutant form of human superoxide dismutase 1 (SOD1G93A) mouse model of ALS all
234 ed intraplatelet expression of p47(phox) and superoxide dismutase-1, suggesting a mechanistic pathway
235 cluding mutant FUS (Fused in sarcoma), SOD1 (superoxide dismutase 1), TDP43 (TAR DNA-binding protein
236 proteins, such as hemoglobin alpha genes and superoxide dismutase 1, that have network functions asso
238 properties change in the presence of mutant superoxide dismutase 1 to contribute to motoneuron injur
239 ouse model expressing a mutant form of human superoxide dismutase-1 with a Gly93-->Ala substitution (
240 ns in mice expressing a mutant form of human superoxide dismutase-1 with a Gly93-->Ala substitution (
241 Additionally, mice transgenic for human superoxide dismutase-1 with G85R mutation show no differ
243 cent lumbar MN cell bodies from ChAT-eGFP or superoxide dismutase 1-yellow fluorescent protein (SOD1Y
244 They include 5 glutathione-S-transferases, superoxide dismutase 1, zeta crystallin, a NADPH quinone
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。